These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 24045448)
1. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival. Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448 [TBL] [Abstract][Full Text] [Related]
2. [Influence of pre-surgical chemotherapy on liver parenchyma and post-surgical outcome of patients subjected to hepatectomy due to colorectal carcinoma metastases]. Gómez-Ramírez J; Martín-Pérez E; Amat CG; Sanz IG; Bermejo E; Rodríguez A; Larrañaga E Cir Esp; 2010 Dec; 88(6):404-12. PubMed ID: 20971458 [TBL] [Abstract][Full Text] [Related]
3. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Morris-Stiff G; Tan YM; Vauthey JN Eur J Surg Oncol; 2008 Jun; 34(6):609-14. PubMed ID: 17764887 [TBL] [Abstract][Full Text] [Related]
4. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638 [TBL] [Abstract][Full Text] [Related]
5. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. Khan AZ; Morris-Stiff G; Makuuchi M J Hepatobiliary Pancreat Surg; 2009; 16(2):137-44. PubMed ID: 19093069 [TBL] [Abstract][Full Text] [Related]
6. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization. Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rather M; Rosso E; Addeo P; Jaeck D; Bachellier P Ann Surg Oncol; 2012 Jul; 19(7):2230-7. PubMed ID: 22402811 [TBL] [Abstract][Full Text] [Related]
7. Consequences of chemotherapy on resection of colorectal liver metastases. Pessaux P; Chenard MP; Bachellier P; Jaeck D J Visc Surg; 2010 Aug; 147(4):e193-201. PubMed ID: 20655821 [TBL] [Abstract][Full Text] [Related]
8. Reversibility of chemotherapy-related liver injury. Vigano L; De Rosa G; Toso C; Andres A; Ferrero A; Roth A; Sperti E; Majno P; Rubbia-Brandt L J Hepatol; 2017 Jul; 67(1):84-91. PubMed ID: 28284915 [TBL] [Abstract][Full Text] [Related]
9. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases. Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348 [TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection. Duwe G; Knitter S; Pesthy S; Beierle AS; Bahra M; Schmelzle M; Schmuck RB; Lohneis P; Raschzok N; Öllinger R; Sinn M; Struecker B; Sauer IM; Pratschke J; Andreou A Eur J Surg Oncol; 2017 Sep; 43(9):1668-1681. PubMed ID: 28599872 [TBL] [Abstract][Full Text] [Related]
11. Impact of chemotherapy-associated liver injury on tumour regression grade and survival in patients with colorectal liver metastases. Zhao J; Sawo P; Rensen SS; Rouflart MMJ; Winstanley A; Vreuls CPH; Verheij J; van Mierlo KMC; Lodewick TM; van Woerden V; van Tiel FH; van Dam RM; Dejong CHC; Olde Damink SWM HPB (Oxford); 2018 Feb; 20(2):147-154. PubMed ID: 28969959 [TBL] [Abstract][Full Text] [Related]
12. Preoperative assessment of chemotherapeutic associated liver injury based on indocyanine green retention test. Russolillo N; Langella S; Perotti S; Lo Tesoriere R; Forchino F; Ferrero A Int J Surg; 2016 Jul; 31():80-5. PubMed ID: 27260311 [TBL] [Abstract][Full Text] [Related]
13. Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases. Hubert C; Lucidi V; Weerts J; Dili A; Demetter P; Massart B; Komuta M; Navez J; Reding R; Gigot JF; Sempoux C Eur J Surg Oncol; 2018 Oct; 44(10):1532-1538. PubMed ID: 30093084 [TBL] [Abstract][Full Text] [Related]
14. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor. Martins J; Alexandrino H; Oliveira R; Cipriano MA; Falcão D; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Prado e Castro L; Castro E Sousa F Eur J Surg Oncol; 2016 May; 42(5):713-21. PubMed ID: 26972374 [TBL] [Abstract][Full Text] [Related]